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Abstract 
Amiloride (0.5 mM) inhibited the rate of entry of Na + into corneal endothelial cells by more than half ((0.76 + 0.10) to (0.21 + 0.10) 
/xEq cm-2 h-~). The same concentration f amiloride caused only minimal disturbance to corneal hydration control by the endothelium 
(range 0-12%). Amiloride (0.5 mM) and acetazolamide (1 mM) reversibly inhibited trans-endothelial short circuit current by about a half. 
Their combined effect was not additive. Acetazolamide (1 raM) reduced net HCO~- flux across the short-circuited endothelium by about 
the same amount ((0.50 + 0.11) /xEq cm -2 h- i )  that amiloride (0.5 mM) reduced Na" entry into the cells ((0.55 + 0.14) /zEq cm -2 
h-~). Low concentrations of amiloride (10 p.M) had little effect on the transport characteristics of the endothelium, indicating that Na + 
entry into the endothelial cells under physiological conditions is not primarily through Na" channels. The data are consistent with an 
Na+/H + exchanger acting in tandem with carbonic anhydrase through a pathway which could have a regulatory role on endothelial 
transport via its effect on Na ÷ re-entry. Residual trans-endotheliai HCO 3 transport, apparently unaffected by amiloride or acetazolamide 
inhibition, is calculated to be of sufficient magnitude to maintain corneal hydration. 
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1. Introduction 
The osmotically active 'pump' in mammalian corneal 
endothelium, which regulates corneal hydration and conse- 
quently corneal transparency [1], has been identified as a 
metabolically coupled flux of HCO 3 ions that flows in the 
direction from corneal stroma to aqueous humour [2-4]. 
Experimental evidence has been used to model the mem- 
brane events which drive the HCO 3 ion current [2,5-7]. 
There are, however, significant differences between these 
models and so there is a need to discriminate between 
some of the options. When HCO 3 is moved across the 
endothelial cell it requires an input of metabolic energy 
[3,4] and there is a consensus that this energy is provided 
by plasma-membrane-bound Na+/K+-ATPase activity 
coupled to the HCO 3 movement [3,8,9]. As HCO 3 is a 
net transported ion, then either its movement from corneal 
stroma into cytoplasm across the basolateral membrane or 
its exit from the cytoplasm into the aqueous across the 
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apical cell membrane must be driven uphill. Localisation 
of the Na * /K  *-ATPase to the basolateral membrane taken 
together with the absence of a net Na + flux in the short- 
circuited preparation ([10,1 I]; in contrast o the net Na + 
flux observed in open circuit preparations, [12,13]) sug- 
gests that the driven step (coupled to the trans-membrane 
Na + gradient) takes place at the basolateral membrane 
[14]. This view is also supported by the relatively high pH 
measured in the cytoplasm, indicating that HCO 3 entry 
into the cell is uphill [15,16]. The various models suggest a
number of possible mechanisms for coupling the trans- 
membrane Na + gradient to HCO 3 movement and this 
coupling has been proposed to be direct, via an 
Na+/HCO3 co-transporter [7,17], or indirect, utilising an 
Na+/K+/2C I  - co-transporter coupled to a C I - /HCO 3 
exchanger [18]. Other models suggest that an Na+/H + 
exchanger located at the basolateral membrane can con- 
tribute to the generation of electrogenic HCO~- movement 
[5,19]. The possible involvement of the Na+-dependent 
HCO3/C I -  exchanger or the recently described 
K+/HCO3 cotransport mechanism have not yet been 
seriously considered for the corneal endothelium [20,21]. 
In this study we carried out a series of experiments to 
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determine whether Na+/H + exchanger activity can con- 
tribute to the trans-endothelial electrogenic HCO 3 flux. 
We conclude that, although most Na + enters the cell via 
the Na+/H + exchanger and that this activity contributes 
to net electrogenic HCO 3 transfer into the aqueous hu- 
mour, in addition to this activity there must be another 
electrogenic HCO 3 transfer mechanism which is primarily 
responsible for net osmotic transfer across the endothe- 
lium. 
2. Methods and materials 
Animals used in all of these experiments were cared for 
using the Code of Practice for the Housing and Care of 
Animals used in Scientific Procedures (1989; HC 107). 
New Zealand White or Dutch rabbits were killed by an 
overdose of sodium pentobarbital administered via the 
marginal ear vein. After death, the eyes were enucleated 
and used immediately or refrigerated at 4°C. All eyes were 
used within 12 h post mortem. 
2.1. Membrane potential (PD m) and intracellular Na + 
concentration ([Na + ]i ) 
De-epithelialised corneas were mounted in a Perspex 
chamber that allowed the cells to be impaled with micro- 
electrodes. Preparations were perfused at 10 ml h -1 with 
Ringer containing (raM): NaC1, 113; KC1, 4.6; NaHCO 3, 
21; MgSO 4, 0.6; glucose, 7.5; reduced glutathione, 1.0; 
Na2HPO 4, 1.0; Hepes, 10; CaCI 2, 1.4; bubbled with 5% 
CO 2, 7% 02 in N 2 and pH set at 7.4. A water jacket 
maintained the preparation at 35°C. 
Filamented borosilicate glass capillaries (1 mm o.d.) 
were pulled into microcapillaries, which when filled with 
154 mM KC1 for measurement of PD m had tip resistances 
of typically 100-200 M O. Before use as ion-selective 
microelectrodes, the glass microcapillaries were baked at 
200°C in air to dry the glass and then in tributylchlorosi- 
lane vapour to prepare the surface for the Na ÷ ionophore 
(Fluka). After filling with ionophore the microcapillaries 
were left overnight with their tips immersed in 154 mM 
NaC1, backfilling the next day with 154 mM KC1 com- 
pleted electrode preparation. Detailed procedures for 
preparation, filling, calibration, mounting and impalement 
of endothelial cells with potential and ion-sensitive micro- 
electrodes have been given previously [14,22]. 
To determine the effect of amiloride on Na ÷ re-entry 
into the cell, measurements of PD m and sodium potential 
(PDNa) were made by impaling the cells with reference 
and Na ÷ selective microelectrodes. Whilst the cells were 
impaled the preparation was perfused firstly with Ringer 
plus amiloride (0.5 mM; the small chamber volume en- 
abled the solution change to be made in approximately 2 
min) and then with Ringer containing amiloride (0.5 mM) 
plus ouabain (0.5 raM). The rate of change of [Na+]i 
calculated from the measurements of PD m and PDNa fol- 
lowing ouabain inhibition is dependent on the passive 
permeability pathways for Na ÷ re-entry into the cell. 
2.2. Specular microscopy 
De-epithelialised rabbit corneas were mounted under 
the specular microscope using the method of Dikstein and 
Maurice [1]. The epithelial surface of the cornea was 
sealed under silicone oil and the endothelial surface per- 
fused at 50 ml h-  1 with Ringer warmed to 35°C. Perfusion 
pressure was set at 15 cm H20 to maintain corneal geome- 
try. After mounting, the preparation was allowed to sta- 
bilise its thickness, which was achieved within 1 h. To 
determine the effect of amiloride on the ability of the 
endothelium to maintain corneal hydration, the preparation 
was stabilised in Ringer for 1 h. followed by Ringer plus 
amiloride (0.5 mM) for 1.5 h, followed by 1 h of Ringer 
plus amiloride (0.5 mM) plus ouabain (0.5 mM). Five 
readings of corneal thickness were taken at 10 min inter- 
vals for the duration of the experiment. In half of the 
preparations (n = 5), the de-epithelialised surface was ex- 
posed to Ringer solution to induce stromal swelling. When 
the preparation had swollen by approximately 200 ~m, the 
Ringer was replaced with silicone oil. In this way it was 
possible to monitor the effect of 0.5 mM amiloride on the 
ability of the endothelium to de-swell a hydrated corneal 
stroma. 
2.3. Trans-endothelial potential difference (PDe), resis- 
tance (Re), short circuit current (s.c.c.) and net HCOf  
and Na + flux 
De-epithelialised corneas were mounted between the 
two halves of a modified Ussing type chamber and per- 
fused at 10 ml h -1 with Ringer solution. The whole 
apparatus was maintained at 35°C by immersion in a 
thermostatically controlled oil bath. Potential difference 
was measured continuously and resistance of the prepara- 
tion (series resistance + endothelial resistance; R t) mea-  
sured  at intervals. Transendothelial resistance (R e) was 
calculated by subtraction of the series resistance (Rs; 
measured at the end of the experiment when the endothe- 
lium had been removed) from R t. A more detailed escrip- 
tion of the apparatus and its use has been given previously 
[23]. Inhibitors were dissolved in Rabbit Ringer and per- 
fused through both half chambers. Perfusion was continued 
until any changes in PD e and R e were stable. R e has been 
shown to be inversely proportional to endothelial cell 
permeability [24] and any significant change in R e was  
considered to be a toxic effect when such changes were 
irreversible. When R e is unchanged, s.c.c. (related to 
HCO 3 pump activity; [10]) is a monitor of endothelial 
HCO 3 transport activity. The effects of amiloride or acet- 
azolamide and the combinations of the two were investi- 
gated. To measure net HCO 3 and Na + fluxes, unidirec- 
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tional fluxes were measured by loading one half chamber 
with radio-labelled HCO 3 and Na + and collecting sam- 
ples from both sides, followed by a reversal of loading. 
The preparation was short-circuited whilst the unidirec- 
tional fluxes were measured. A detailed description of the 
short-circuiting technique and measurement of unidirec- 
tional ion fluxes is given elsewhere [10,24]. The effect of 1 
mM acetazolamide on unidirectional f uxes was measured. 
The requirement of several hours of stability for flux 
investigations on these preparations debarred the use of 
amiloride. 
3. Results 
In a series of preliminary experiments amiloride (0.5 
mM) was found to hyperpolarise PD m from -29 .5  + 5.7 
to -41 .0  + 4.0 mV (mean + S.E., n = 13) over a period 
of about 20 min. In these experiments, where cells were 
impaled with PD m- and Na+-selective microelectrodes si- 
multaneously, amiloride (0.5 mM) induced a hyperpolari- 
sation of both PD m and the potential detected with the 
sodium-selective microelectrode (PDNa). Intracellular Na ÷ 
concentration ([Na+]i) calculated from these values de- 
creased significantly from (12.2 ___ 1.6) to (7.7 + 1.5) mM 
(mean ___ S.E., n = 9, P < 0.05) after exposure to 0.5 mM 
amiloride. When the cells were perfused with amiioride + 
ouabain, both PD m and PDy a depolarised. Fig. I shows a 
typical trace of one such experiment. The pattern of depo- 
larisation was reproducible and from it the initial rate of 
influx of Na + (across the baso-lateral membrane) in the 
presence of amiloride (plus ouabain) was calculated to be 
0,21 ___ 0.04 /.~Eq cm-= h-  ~ (mean ___ S.E., n = 7). This 
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Fig. 1. A typical trace of rabbit corneal endothelial cell PD~ (lower line) 
and PD,, (upper line). Trace A shows the depolarising effect of ouabain 
(0.5 mM). Trace B shows the hyperpolarising effect of amiloride (0.5 
raM) and the change in the pattern of depolarisation when amiloride + 
ouabain (0.5 raM) was added. Amiloride is seen to slow considerably the 
ouabain-induced depolarisation. 
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Fig. 2. A typical trace of experiment todetermine the effect of amiloride 
(0.5 mM) on the ability of rabbit corneal endothelium tomaintain corneal 
thickness. The lower trace shows a normal cornea, the upper trace shows 
a cornea that has been allowed to swell prior to the start of the 
experiment. The amiloride is seen to have little or no effect on mainte- 
nance of hydration or deturgescence from the swollen state. The addition 
of ouabain (0.5 mM) showed the preparation to be responsive to inhibi- 
tion. 
was significantly less than the uninhibited influx of Na + 
(with ouabain alone) which was 0.76 + 0.05 /zEq cm -2 
h-  1 (mean + S.E., n = 4, P < 0.05). These observations 
indicate the presence, in the basolaterai membrane of these 
cells, of an amiloride-inhibitable traffic protein which is 
responsible for a major part of the re-entry of Na ÷ into 
fresh corneal endothelial cells. The elimination of Na ÷ 
re-entry via the Na+/H ÷ exchanger could explain the 
reduction in [Na*] i after amiloride inhibition, whilst the 
removal of this permeability pathway for Na ÷ across the 
membrane might explain the observed hyperpolarisation f 
the membrane after amiioride inhibition (towards the K ÷ 
equilibrium potential). 
The ability of the endothelium to maintain corneal 
thickness and hydration and the effect of amiloride is 
shown by the traces in Fig. 2. Amiloride (0.5 mM) had no 
effect on the ability of the endothelium to maintain physio- 
logical thickness, nor did it affect its ability to thin a 
pre-swollen cornea. Pre-swollen comeas thinned at (36.0 
+ 3.0) /xm h -I (mean + S.E., n---5) in the absence or 
presence of amiloride. Addition of ouabain showed the 
amiloride exposed preparation still to be responsive to 
transport inhibition. 
At 0.5 mM, amiloride reduced s.c.c, from (37.9 ___ 2.5) 
to (18.7 +__ 1.8) /zA cm -2 an inhibition of (51.3 _+ 2.4)% 
and caused no significant change in R e, (15.0 +__ 0.9) to 
(14.1 + 0.8) 1"2 cm 2 (mean + S.E., n = 11). At or below 
0.5 mM, the amiloride effects were fully reversible. A 
typical trace showing the inhibition and reversibility of 
effect of 0.5 mM amiloride is shown in Fig. 3. At concen- 
trations of amiloride greater than 0.5 mM, R e was irre- 
versibly reduced, indicating a possible toxic or non-specific 
effect of the drug on the endothelial cells. The effect of 1.0 
mM acetazolamide was similar to the effect of 0.5 mM 
amiloride; at 1.0 mM acetazolamide r duced s.c.c, from 
(37.1 + 1.8) to (20.8 +4.0)  #A cm -2 an inhibition of 
(37.1 + 5.0)%, R e was unchanged (18.3 4- 3.0) to (18.2 _ 
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Fig. 3. A typical trace of the effect of amiloride (0.5 mM) on trans-endo- 
thelial potential difference. Amiloride was added at the open arrow, 
normal Ringer was perfused at the closed arrow. The dashed area on the 
time axis represents a period of 115 min during which time PD e was 
stable. The amiloride effect was completely reversible. Half-exchange 
time for the chamber is approx. 5 min. Gaps in the trace indicate points at 
which R e was measured, it remained unchanged throughout the experi- 
ment. 
3.0) D cm 2 (mean ___ S.E., n = 4). At concentrations above 
1.0 mM there was a small change in R e. At or below 1 
mM all effects were fully reversible. A typical trace show- 
ing the effect of the combined addition of amiloride (0.5 
mM) and acetazolamide (1.0 mM) on s.c.c, is shown in 
Fig. 4. The combination of inhibitors reduced s.c.c, by 
(62.7 + 1.9)% (mean ___ S.E., n = 6). Whilst this reduction 
was significantly greater than the single inhibitor effect, 
P < 0.05, Student's t-test, it was very much less than the 
inhibition expected (88.4%) if the inhibitors were acting 
independently and additively. The order of presentation of
the drugs was not important; the combination of inhibitors 
decreased s.c.c, to (60.3 ___ 2.5)% when amiloride was pre- 
sented first and (65.0 + 2.4)% when acetazolamide was 
presented first (mean +_ S.E., n = 3). 
The apparent contradiction in the above data; that in- 
hibitors which reduce trans-endothelial s.c.c. (considered 
to be representative of endothelial pump activity, [10]) and 
Na ÷ exchange rates across the basolateral membrane have 
little or no effect on the ability of the endothelium to 
maintain corneal stromai hydration, led us to repeat pub- 
lished reports of inhibitor effect on ion fluxes across the 
preparation. Amiloride-inhibited preparations were not suf- 
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Fig. 4. Typical traces to show the inhibitory effects of amiloride (0.5 
mM), E ] - -13 ;  acetazolamide (1 mM), O O; and 
both, (3 (3, on rabbit corneal endothelial cell trans-endothelial 
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Fig. 5. Unidirectional ion fluxes across corneal endothelial cells mounted 
in vitro. Open circles indicate HCO 3 fluxes across a control cornea, 
filled circles are from a cornea exposed to 1 mM acetazolamide. Open 
squares indicate Na + fluxes across a control cornea, filled squares are 
from a cornea exposed to 1 mM acetazolamide. 
ficiently stable for a long enough time period to make 
measurements of trans-endothelial net ion fluxes. How- 
ever, acetazolamide (1 mM) reduced net HCO 3 flux, 
under short-circuited conditions, from (1.20 +0.10) to 
(0.69 + 0.06) /zEq cm 2 h-  1 (mean ___ S.E., n = 3), i.e., 
by 42.7%. In these experiments s.c.c, was reduced from 
(1.76 + 0.2) to (1.05 + 0.1)/zEq cm -2 h -t .  In neither the 
control nor the acetazolamide-inhibited preparation was 
there a significant net Na + flux across the short-circuited 
endothelium, Fig. 5. 
4. Discussion 
Amiloride (0.5 mM) reduced the rate of Na + entry into 
corneal endothelial cells by more than half. Amiloride (0.5 
mM) and acetazolamide (1 mM) each reversibly inhibited 
trans-endothelial s.c.c, by about half and at these concen- 
trations neither drug significantly affected (< 5%) the 
passive permeability of the endothelial monolayer. When 
added simultaneously to the endothelium, if their individ- 
ual effects had been additive, an inhibition of 88% would 
be expected. The observed inhibition of only 62% suggests 
that the drugs could be acting on the same pathway [5]. 
Preliminary data on the dose-response curve for both 
amiloride and acetazolamide suggested that around 60% of 
s.c.c, is likely to be the maximum inhibition with either 
drug. However, the concentrations that elicited 60% inhibi- 
tion (1.0 mM amiloride and 5 mM acetazolamide) caused 
irreversible permeability increases of (19.6 ___ 6.7)% for 
amiloride and (14.4 + 2.4)% (mean + S.E., n = 3) for 
acetazolamide. These irreversible changes associated with 
the higher and probably saturating doses of acetazolamide 
or amiloride were too unstable to allow systematic nvesti- 
gations of the transport properties of the endothelium and 
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were consequently not pursued. The concentrations u ed in 
these experiments (0.5 mM amiloride and 1 mM acetazol- 
amide) we estimate, gave 80% saturation. Even at the 
lower concentrations of amiloride (0.5 mM) it was not 
possible to maintain stable preparations for the several 
hours required to carry out unidirectional isotopic flux 
studies. 
It was of interest to note that the reduction in net 
HCO 3 flux across the preparation after inhibition with 1 
mM acetazolamide was about the same as reported previ- 
ously [25] and was about the same as the amiloride in- 
duced reduction in Na ÷ flux into the cell. Net fluxes of 
Na + were, as reported before [10], not observed across the 
short circuited endothelium (in contrast o the well estab- 
lished open circuit net Na ÷ flux). These data tend to 
confirm the proposal that a circulating basolateral Na ÷ 
flux into and out of the cell drives the net HCO 3 flux 
across the cell. The stoichiometry suggests that for each 
Na ÷ driven into the cell across the basolaterai membrane, 
one HCO 3 exits across the apical surface of the cell via 
the acetazolamide/amiloride inhibitable pathway. Because 
low doses of amiloride, capable of blocking Na- channels 
had no effect on the endothelial transport characteristics, 
we conclude that Na ÷ entry into the cell via this pathway 
is likely to be via the Na÷/H + exchanger whose presence 
has been proposed from electrophysiological studies [26] 
and from studies on vesicles prepared from purified corneal 
endothelial cell plasma membranes [27]. We propose a 
model that describes HCO 3 exit from corneal endothelial 
cells by the pathway illustrated in Fig. 6. 
There seems to be relatively little osmotic activity 
associated with this pathway. In seven of our corneal 
preparations the exposure of the endothelium to 0.5 mM 
amiloride had no significant effect (<  10%) on either 
corneal thickness in stabilised preparations (n = 4) or on 
deturgescence rates of pre-swollen corneas (n = 3) There 
was a marginal effect on the other five preparations, but 
3 
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Fig. 6. k model of that proportion of endothelial HCO~- transport that is 
amiloride and acetazolamide inhibitable. Components are numbered: I,
Na+/K+-ATPase; 2, Na+/H + exchanger; 3, carbonic anhydrase; 4, 
unidentified anion transporter. This HCO 3 transport system is electro- 
genic but shows little osmotic activity. 
always less than 20% inhibition (ouabain-inhibited prepa- 
rations were taken to show 100% inhibition of trans-endo- 
thelial osmotic transfer). A similar range of results has 
been reported for acetazolamide inhibition of osmotic 
transfer, varying between 0% inhibition up to 25% inhibi- 
tion [28,29]. It is noticeable that osmotic transfer inhibition 
by acetazolamide seems to increase progressively with 
time, perhaps reflecting not only osmotic transfer charac- 
teristics but also possibly diminishing endothelial barrier 
characteristics. Kuang et al. [28] showed little or no imme- 
diate effect on fluid transfer of 5 mM acetazolamide but a 
progressive decrease over a 4 h period. The progressive 
change of fluid transfer characteristics i close to the 
progressive increase in endothelial permeability which we 
have noted during the course of this study. Carbonic 
anhydrase inhibition with other drugs such as ethoxyzo- 
lamide, also shows variations in osmotic transfer inhibi- 
tion. However, inspection of the primary data suggests that 
the magnitude of the inhibition increases progressively 
with time. In all cases, in the first hour of study it appears 
that no-one has reported an apparent osmotic transfer 
inhibition greater than about 25% [5,29,30]. The published 
reports of amiloride inhibition of osmotic transfer have 
used 1 mM amiloride [31] which concentration we found 
to be associated with secondary effects on the tissue. In 
this study we find a 0-15% inhibition of osmotic transfer 
in the presence of amiloride under the same incubation 
conditions that produces a 42% reduction in net HCO; 
transfer and a greater than 50% inhibition of Na + entry 
into the cells. 
Whilst the pathway is seen from the s.c.c, measure- 
ments to be electrogenic and the drugs act quickly in 
reducing s.c.c., the osmotic transfer data suggest that there 
is relatively little associated osmotic activity. In the model 
shown in Fig. 6, HCO 3 and H ÷ are produced inside the 
cell by the carbonic anhydrase catalysed reaction between 
H20 and CO 2. The HCO; produced exits the cell across 
the apical membrane via a traffic protein yet to be deter- 
mined and it is this component of the total HCO; net flux 
that is eliminated by inhibition with acetazolamide. The 
H ÷ produced exits the cell via the Na+/H + exchanger 
located on the basolateral membrane, which is driven by 
the energy of Na ÷ re-entering the cell down its electro- 
chemical gradient after being driven out by Na+/K  +- 
ATPase also located on the basolateral membrane. At 
steady state, Na + recycles across the basolateral mem- 
brane with exit flux via Na+/K÷-ATPase qual to its entry 
flux via the Na+/H ÷ exchanger and, it has been sug- 
gested, by at least one other route [27]. The consequence is 
that passive Na ÷ entry via the Na+/H + exchanger is 
non-electrogenic: the Na ÷ is simply recycling across the 
basolateral membrane. H* exit via the exchanger repre- 
sents a net movement of positive charge into Descemets 
membrane. The electrogenic effect of the flux of H ÷ into 
Descemets and the flux of negative ions (HCO 3) into the 
aqueous are, electrically, additive. In conclusion we can 
C.G. Wigham et al./ Biochimica et Biophysica Acta 1279 (1996) 104-110 109 
see thaf the pathway illustrated in Fig. 6 is electrogenic, 
with a movement of opposite charges in opposite direc- 
tions across the apical and basolateral membranes, which 
manifests itself as a component of the s.c.c, across the 
preparation. 
In order to generate and maintain an osmotic gradient 
across an epithelium, clearly it would be neccessary to 
effect a net osmotic transfer across the epithelium in open 
circuit (although it must be acknowledged that there is, as 
yet, no generally agreed model to explain local osmotic 
coupling). There is a method by which the metabolically 
driven movements of H ÷ and HCO 3 out of opposite faces 
of the corneal endothelium could generate, in open circuit, 
an osmotic gradient across the monolayer. The method 
would require the paracellular route to be permselective. 
Experimentally, the endothelium shows a very slight cation 
selectivity [24], but for practical purposes, the monolayer 
is effectively non-selective and is therefore unlikely to 
produce any significant osmotic gradient across the en- 
dothelium in open circuit from the pathway shown in Fig. 
6. Whilst the acetazolamide/amiloride-inhibitable pathway 
of HCO 3 transport across corneal endothelium proposed 
here probably places a considerable demand on the 
metabolism of the cells, we do not believe that it is 
primarily responsible for the regulation of corneal hydra- 
tion by osmotic transfer. 
It seems clear that the amiloride/acetazolamide- 
inhibitable pathway illustrated in Fig. 6 does not contribute 
100% of the HCO3-dependent transport activity across the 
corneal endothelium and nor is it primarily responsible for 
maintaining corneal hydration. The question arises: does 
the other HCO3-dependent pathway, not yet characterised 
here but variously proposed to involve Na+/HCO3 re-en- 
try or Na+/K+/C1-  re-entry of Na + into the cell, have 
sufficient activity to maintain hydration? In examining this 
quantitative question we used the mathematical description 
of the endothelial pump/leak mechanism originally de- 
rived by Hedbys and Mishima [32] and independently 
derived by Hodson [33] which has the equation: 
(.o 
Jp = --AT 
Or 
where Jp is the osmotically active HCO~- pump, o- is the 
endothelial reflection coefficient to HCO~-, oJ is the en- 
dothelial permeability to HCO~- and A 7 is nowadays 
given as corneal gel pressure [34]. 
Independent measurements of o', oJ and A7 may be 
combined to predict the magnitude of the pump, Jp, 
needed to sustain corneal hydration. In order to derive a 
semi-quantitative estimate, we used the values of these 
parameters previously published by this laboratory: o" = 1 
[35]; oJ = 0.214 cm h -1 [24]; A 7 = 2.6 mM [34]; and give 
a predicted value of Jp of 0.55 /zEq HCO 3 cm -2 h -1 . It 
seems that from the acetazolamide-inhibited preparations, 
where the residual HCO~- net flux is about 0.6 /zEq 
HCO~- cm -2 h - l ,  that there is likely to be sufficient 
activity to maintain corneal hydration. It is interesting to 
note that the residual Na ÷ influx after amiloride inhibition 
suggests a 1 Na ÷ (influx): 2 HCO 3 (efflux) stoichiometry. 
This ratio is consistent with the model of direct basolateral 
coupling via a 1 Na+/2 HCO 3 symport [2,6]. So far, we 
have been unable to detect any such direct HCO 3- or 
HCO3-gradient-dependent Na ÷ influx in experiments with 
plasma membrane vesicles isolated from corneal endothe- 
lial cells [27]. 
We provide evidence in support of the existence of an 
electrogenic HCO 3 pathway in corneal endothelium in- 
cluding a baso-lateral Na+/H ÷ exchanger and cytoplas- 
mic carbonic anhydrase. As the pathway is only marginally 
involved in osmotic transfer across the corneal endothe- 
lium we suggest hat it probably has a regulatory role 
which could involve pH regulation or might provide a 
mechanism for Na ÷ reentry into the cell that dissipates the 
Na ÷ gradient across the basolateral membrane and reduces 
the ion gradient hat is driving the osmotic pump re-entry 
mechanism. However, we believe from unpublished evi- 
dence from this laboratory that the pathway we describe 
here may be involved in regulating the permeability of the 
endothelial monolayer. 
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